Lv41
530 积分 2022-04-16 加入
LD-110, a potent LSD1 PROTAC degrader, suppresses tumor growth by inducing ER stress and apoptosis
3小时前
待确认
Disruption of Cell Cycle Machinery in Pancreatic Cancer
4个月前
已完结
Methods for Synchronizing Cells at Specific Stages of the Cell Cycle
4个月前
已完结
Crystal Structure of human FABP4 in complex with 4-(1-methyl-2-phenylindol-3-yl)cyclohexane-1-carboxylic acid
1年前
已关闭
Discovery of Covalent MLKL PROTAC Degraders via Optimization of a Theophylline Derivative Ligand for Treating Necroptosis
1年前
已完结
Design, synthesis, and biological evaluation of novel highly selective non-carboxylic acid FABP1 inhibitors
1年前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
1年前
已完结
Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysi
1年前
已完结
Serum liver fatty acid binding protein shows good correlation with liver histology in NASH
1年前
已关闭
Therapeutic Targeting of Hepatic ACSL4 Ameliorates Non-alcoholic Steatohepatitis in Mice
2年前
已完结
Improved quality of life and dyspnea with erdosteine in COVID-19 patients after hospital discharge
皖公网安备34019202002308
